Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Rupert Kaul, University of Toronto
ClinicalTrials.gov Identifier:
NCT00946556
First received: July 23, 2009
Last updated: March 21, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2011
  Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)